2022-09-20T11:49:00Z
2023-10-31T06:10:25Z
2022-10
2022-09-20T11:49:00Z
Polycythemia vera (PV) is one of the most common chronic myeloproliferative neoplasms, yet, little data is available on the epidemiology of PV in Spain and the costs of its management. This study aimed to evaluate the hospital incidence and mortality rate of PV in Spain, and to estimate hospital medical costs.
Article
Accepted version
English
Policitèmia; Política sanitària; Cost de l'assistència sanitària; Polycythemia; Medical policy; Cost of medical care
Informa Healthcare
Versió postprint del document publicat a: https://doi.org/10.1080/14737167.2022.2029413
Expert Review of Pharmacoeconomics & Outcomes Research, 2022, vol. 22, num. 6, p. 965-970
https://doi.org/10.1080/14737167.2022.2029413
(c) Informa Healthcare, 2022
Economia [1045]